首页> JAMA oncology> Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).

Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).

导出 LinkOut

翻译打印收藏纠错

第一作者： Paul W,Sperduto

第一单位： Minneapolis Radiation Oncology, Minneapolis, Minnesota2University of Minnesota Gamma Knife Center, Minneapolis.

作者： Paul W,Sperduto ^[1] ; T Jonathan,Yang ^[2] ; Kathryn,Beal ^[2] ; Hubert,Pan ^[3] ; Paul D,Brown ^[3] ; Ananta,Bangdiwala ^[4] ; Ryan,Shanley ^[4] ; Norman,Yeh ^[5] ; Laurie E,Gaspar ^[5] ; Steve,Braunstein ^[6] ; Penny,Sneed ^[6] ; John,Boyle ^[7] ; John P,Kirkpatrick ^[7] ; Kimberley S,Mak ^[8] ; Helen A,Shih ^[8] ; Alex,Engelman ^[9] ; David,Roberge ^[10] ; Nils D,Arvold ^[11] ; Brian,Alexander ^[11] ; Mark M,Awad ^[12] ; Joseph,Contessa ^[12] ; Veronica,Chiang ^[12] ; John,Hardie ^[13] ; Daniel,Ma ^[13] ; Emil,Lou ^[14] ; William,Sperduto ^[7] ; Minesh P,Mehta ^[9]

作者单位： Minneapolis Radiation Oncology, Minneapolis, Minnesota2University of Minnesota Gamma Knife Center, Minneapolis. ^[1] Sloan Kettering Cancer Center, New York, New York. ^[2] MD Anderson Cancer Center, Houston, Texas. ^[3] University of Minnesota, Masonic Cancer Center, Biostatistics, Minneapolis. ^[4] University of Denver, Denver, Colorado. ^[5] University of California, San Francisco. ^[6] Duke University, Durham, North Carolina. ^[7] Massachusetts General Hospital, Boston. ^[8] University of Maryland, Baltimore. ^[9] University of Montreal Health Centre, Montreal, Quebec, Canada. ^[10] Dana Farber Cancer Institute, Boston, Massachusetts. ^[11] Yale University, New Haven, Connecticut. ^[12] Mayo Clinic, Rochester, Minnesota. ^[13] University of Minnesota, Department of Hematology Oncology, Minneapolis. ^[14]

医学主题词腺癌(Adenocarcinoma);老年人(Aged);脑肿瘤(Brain Neoplasms);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);综合疗法(Combined Modality Therapy);流行病学方法(Epidemiologic Methods);女(雌)性(Female);人类(Humans);肺肿瘤(Lung Neoplasms);男(雄)性(Male);预后(Prognosis);受体蛋白质酪氨酸激酶类(Receptor Protein-Tyrosine Kinases);回顾性研究(Retrospective Studies)

DOI 10.1001/jamaoncol.2016.3834

PMID 27892978

发布时间 2022-04-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览31

JAMA oncology

2017年3卷6期

827-831页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览31

点击下载本期目录封面

JAMA oncology

2017年3卷6期

827-831页

检索历史清除

Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).

JAMA oncology

相似文献

同项目论文

JAMA oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).

JAMA oncology

相似文献

同项目论文

JAMA oncology

相关期刊

检索历史清除